Patients with chronic lymphocytic leukaemia (CLL) do not necessarily need to pause therapy while receiving COVID vaccination, according to the findings of a British-led study.
The study found that patients can continue taking Bruton Tyrosine Kinas...
1 month ago
The first approved treatment for previously untreated, late stage, classical Hodgkin’s lymphoma is to be available on the NHS in England, it has been announced.
The treatment, brentuximab vedotin, is to be given with other therapies and is likely...
1 month ago
